BG Medicine, Inc.
(Other OTC/NBB : BGMD)

( )
BGMD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading BGMD News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
5.19%82.311.8%$740.58m
BIIBBiogen Inc.
1.75%228.521.0%$544.75m
CELGCelgene Corporation
2.56%97.281.2%$463.99m
AMGNAmgen Inc.
2.66%148.421.0%$431.37m
ANACAnacor Pharmaceuticals, Inc.
-0.14%99.0615.2%$318.93m
REGNRegeneron Pharmaceuticals, Inc.
2.64%339.783.1%$318.00m
ALXNAlexion Pharmaceuticals, Inc.
2.73%114.942.5%$298.51m
ILMNIllumina, Inc.
-0.35%135.014.9%$164.34m
VRTXVertex Pharmaceuticals Incorporated
4.51%83.442.6%$130.39m
BMRNBioMarin Pharmaceutical Inc.
6.54%79.494.0%$128.15m
MDVNMedivation, Inc.
2.08%57.792.8%$121.27m
CPXXCelator Pharmaceuticals, Inc.
0.10%30.208.5%$106.05m
SRPTSarepta Therapeutics, Inc.
5.07%17.8149.4%$103.08m
AAgilent Technologies, Inc.
1.99%43.101.0%$101.23m
ACADACADIA Pharmaceuticals Inc.
4.49%31.6619.6%$96.80m

Company Profile

BG Medicine, Inc. engages in the research and development, clinical research, manufacture and sale of diagnostic products for heart failure and related disorders. It distributes its products among clinical laboratories, hospitals and health care provider. The company was founded in February 2000 and is headquartered in Waltham, MA.